China Universal Asset Management Company’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
19,181
+870
| +5% | +$11.4K | 0.02% | 291 |
|
|
2025
Q1 | $263K | Sell |
18,311
-598
| -3% | -$8.6K | 0.02% | 291 |
|
|
2024
Q4 | $317K | Buy |
18,909
+5,316
| +39% | +$89K | 0.03% | 293 |
|
|
2024
Q3 | $217K | Buy |
13,593
+6,785
| +100% | +$108K | 0.02% | 294 |
|
|
2024
Q2 | $61.5K | Sell |
6,808
-4,009
| -37% | -$36.2K | 0.01% | 344 |
|
|
2024
Q1 | $122K | Buy |
10,817
+4,423
| +69% | +$50K | 0.02% | 350 |
|
|
2023
Q4 | $50.9K | Buy |
6,394
+5,037
| +371% | +$40.1K | 0.01% | 369 |
|
|
2023
Q3 | $8.78K | Buy |
1,357
+666
| +96% | +$4.31K | ﹤0.01% | 355 |
|
|
2023
Q2 | $4.28K | Sell |
691
-21
| -3% | -$130 | ﹤0.01% | 384 |
|
|
2023
Q1 | $2.74K | Buy |
712
+179
| +34% | +$689 | ﹤0.01% | 422 |
|
|
2022
Q4 | $1.65K | Buy |
533
+52
| +11% | +$161 | ﹤0.01% | 383 |
|
|
2022
Q3 | $2K | Buy |
+481
| New | +$2K | ﹤0.01% | 346 |
|